Yuko Matsunaga, MD

Medical Director
Shionogi Inc.
Florham Park, New Jersey

Disclosure: Shionogi Inc.: Employee

Presentation(s):

• LB4 - Efficacy and Safety of Cefiderocol versus High-Dose Meropenem in Patients with Nosocomial Pneumonia – Results of a Phase 3 Randomized, Multicenter, Double-Blind, Non-Inferiority Study

  Thursday, October 3
  2:15 PM – 2:25 PM